Christopher M. Smith - 23 Feb 2024 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
23 Feb 2024
Net transactions value
$0
Form type
4
Filing time
27 Feb 2024, 16:28:18 UTC
Previous filing
08 Jun 2023
Next filing
04 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEO Common Stock 602,219 23 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +287,940 $0.000000 287,940 23 Feb 2024 Common Stock 287,940 $16.45 Direct F6
transaction NEO Restricted Stock Unit Award $0 +172,239 $0.000000 172,239 23 Feb 2024 Common Stock 172,239 $0.000000 Direct F4, F7
transaction NEO Performance Stock Unit Award $0 +172,240 $0.000000 172,240 23 Feb 2024 Common Stock 172,240 $0.000000 Direct F4, F8
holding NEO Stock Option (Right to Buy) 694,444 23 Feb 2024 Common Stock 694,444 $12.62 Direct F1
holding NEO Stock Option (Right to Buy) 269,841 23 Feb 2024 Common Stock 269,841 $19.65 Direct F2
holding NEO Restricted Stock Unit 144,190 23 Feb 2024 Common Stock 144,190 $0.000000 Direct F3, F4
holding NEO Performance Stock Unit 144,190 23 Feb 2024 Common Stock 144,190 $0.000000 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F2 On May 11, 2023, Mr. Smith was granted 269,841 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F3 On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F4 Once vested, the shares of common stock are not subject to expiration.
F5 On May 11, 2023, Mr. Smith was granted 144,190 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 216,285. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
F6 On February 23, 2024, Mr. Smith was granted 287,940 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F7 On February 23, 2024, Mr. Smith was granted 172,239 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F8 On February 23, 2024, Mr. Smith was granted 172,240 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 258,360. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.